GSK plc

Q3 2026 13F-HR Holdings

Location
London, X0
Holdings as of
9/30/2026
Date filed
11/5/2026
Form type
13F-HR
Num holdings
13
Total value ($000)
$497,015
Net value change ($000)
-105,205 (-17.5%)
New positions
1
Sold out positions
1
Turnover %
34.9%
Sector allocation + QoQ delta (equities-only)
Prev filing: 8/13/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
WAVE LIFE SCIENCES INC 67,509 NEW
VIR 8,466 9.7%
IDYA 1,534 3.1%
FULC 71 1.1%
Top Reduces (Value $000, Stocks/ETFs)
WAVE LIFE SCIENCES LTD -106,007 -100.0%
CRSP -31,355 -17.9%
BNTX -17,082 -20.6%
SPRO -9,190 -45.2%
CYTK -6,564 -22.6%
LYEL -6,444 -30.3%
CVRX -3,416 -66.0%
RGNX -1,208 -37.1%
BCYC -856 -13.2%
NKTX -662 -7.4%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type